文献速递瓣膜病与结构性心脏病

美国老年人瓣膜性心脏病人群患病率:PREVUE-VALVE研究

Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study.
PubMed 文献 · J Am Coll Cardiol · 2026-01-01

PREVUE-VALVE是一项去中心化全国性研究,随机选取65-85岁既往在CVS或Walgreens配药者,入户完成经胸超声心动图,样本n=3000。加权后≥中度瓣膜性心脏病患病率为8.2%,临床显著瓣膜性心脏病为18.4%,三尖瓣反流最常见,年龄增长与患病率升高相关。

要点

  • 美国65-85岁人群中≥中度瓣膜性心脏病加权患病率为8.2%。
  • 临床显著瓣膜性心脏病加权患病率为18.4%,三尖瓣反流最常见。
  • 年龄增长而非性别与瓣膜性心脏病患病率升高相关。

核心结论

  • 在美国老年人中瓣膜性心脏病常见,并呈现重要的年龄相关和瓣膜特异性模式。
  • PREVUE-VALVE证明大规模去中心化心血管影像研究可行,为瓣膜性心脏病负担的临床与政策规划提供当代基础。

研究设计与样本

  • 去中心化研究,随机选取65-85岁既往在CVS或Walgreens药房配药者,通过电子邮件、直邮或短信联系邀请参与。
  • 入组参与者在家中完成研究流程,包括全面的经胸超声心动图,样本n=3000。
  • 主要终点为加权至反映美国人群的≥中度瓣膜性心脏病患病率,共同主要终点为临床显著瓣膜性心脏病患病率。

主要发现

  • 样本中位年龄71岁,女性57.1%,非西班牙裔黑人14.6%,西班牙裔9.4%。
  • ≥中度瓣膜性心脏病加权患病率为8.2%(95%CI:7.0%-9.5%),临床显著瓣膜性心脏病为18.4%(95%CI:16.7%-20.2%)。
  • 三尖瓣反流是最常见病变,其次为主动脉瓣狭窄、二尖瓣反流、主动脉瓣反流和二尖瓣狭窄。
  • 年龄增长与患病率升高相关,性别无此关联。
  • 年龄和性别校正分析中,非西班牙裔黑人任何瓣膜性心脏病患病率低于非西班牙裔白人(校正RR:0.91;95%CI:0.83-0.99),主要由主动脉瓣狭窄和反流率较低驱动;西班牙裔与非西班牙裔个体间无显著校正差异。

关键数值与推荐

  • ≥中度瓣膜性心脏病加权患病率8.2%(95%CI:7.0%-9.5%)。
  • 临床显著瓣膜性心脏病加权患病率18.4%(95%CI:16.7%-20.2%)。
  • 非西班牙裔黑人对比非西班牙裔白人任何瓣膜性心脏病校正RR:0.91(95%CI:0.83-0.99)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Valvular heart disease (VHD) is associated with substantial morbidity, mortality, and health care costs, yet its contemporary prevalence among older adults in the United States is unknown. OBJECTIVES: We performed a decentralized study of older adults (PREVUE-VALVE) to determine the population prevalence of VHD among older Americans. METHODS: Individuals 65-85 years old who previously filled a prescription at CVS or Walgreens pharmacies were randomly selected; contacted via e-mail, direct mail, or text messaging; and invited to participate. Enrolled participants completed study procedures in their homes, including a comprehensive transthoracic echocardiogram. The primary endpoint was the prevalence of moderate or greater (≥ moderate) VHD, weighted to reflect the U.S. POPULATION: The co-primary endpoint was the prevalence of clinically significant VHD, which also included mild-to-moderate regurgitant disease. RESULTS: The study sample (n = 3,000) was representative of older Americans (median age 71 years, 57.1% female, 14.6% non-Hispanic Black, 9.4% Hispanic). The weighted prevalence of ≥ moderate VHD was 8.2% (95% CI: 7.0%-9.5%), which increased to 18.4% (95% CI: 16.7%-20.2%) for clinically significant VHD. Tricuspid regurgitation was the most common lesion, followed by aortic stenosis, mitral regurgitation, aortic regurgitation, and mitral stenosis. Older age, but not sex, was associated with greater prevalence. In age- and sex-adjusted analyses, non-Hispanic Black individuals had a lower prevalence of any VHD compared with non-Hispanic White individuals (adjusted RR: 0.91; 95% CI: 0.83-0.99), driven predominantly by lower rates of aortic stenosis and regurgitation. There were no significant adjusted differences in VHD prevalence between Hispanic and non-Hispanic individuals. Extrapolation of these data to the U.S. population indicates that at least 4.7 million 65-85-year-olds currently have ≥ moderate VHD, and 10.6 million currently have clinically significant VHD-values that are projected to increase to 6.5 and 14.7 million, respectively, by 2060. CONCLUSIONS: In this national in-home echocardiography study, VHD was common among older adults, with important age-related and valve-specific patterns. PREVUE-VALVE establishes the feasibility of large-scale decentralized cardiovascular imaging studies and provides a contemporary foundation for clinical and policy planning related to the burden of VHD. (Age- and Sex-Specific Prevalence of Acquired Valvular Heart Disease (PREVUE-VALVE; NCT05357404).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Brener MI, Chuang ML, Nishimura R, et al. Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study. J Am Coll Cardiol. 2026. PMID: 42300818. doi:10.1016/j.jacc.2026.02.5137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。